4//SEC Filing
KEEGAN JOSEPH D 4
Accession 0000914190-25-000024
CIK 0000842023other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 5:37 PM ET
Size
16.5 KB
Accession
0000914190-25-000024
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
KEEGAN JOSEPH D
Director
Transactions
- Award
Common Stock
2025-10-30+1,640→ 15,411 total - Award
Stock Options (Right to Buy)
2025-10-30+3,777→ 3,777 totalExercise: $60.96Exp: 2035-10-30→ Common Stock (3,777 underlying)
Holdings
- 7,592
Stock Options (Right to Buy)
Exercise: $44.96From: 2019-10-24Exp: 2028-10-25→ Common Stock (7,592 underlying) - 8,044
Stock Options (Right to Buy)
Exercise: $50.41From: 2020-10-24Exp: 2029-10-24→ Common Stock (8,044 underlying) - 6,028
Stock Options (Right to Buy)
Exercise: $63.92From: 2021-10-28Exp: 2030-10-29→ Common Stock (6,028 underlying) - 2,532
Stock Options (Right to Buy)
Exercise: $128.81From: 2022-10-27Exp: 2031-10-28→ Common Stock (2,532 underlying) - 12,500
Stock Options (Right to Buy)
Exercise: $31.26From: 2018-10-25Exp: 2027-10-26→ Common Stock (12,500 underlying) - 3,460
Stock Options (Right to Buy)
Exercise: $73.94From: 2023-10-26Exp: 2032-10-27→ Common Stock (3,460 underlying) - 3,511
Stock Options (Right to Buy)
Exercise: $68.37From: 2025-10-24Exp: 2034-10-24→ Common Stock (3,511 underlying) - 3,937
Stock Options (Right to Buy)
Exercise: $61.51From: 2024-10-24Exp: 2033-10-26→ Common Stock (3,937 underlying)
Footnotes (1)
- [F1]This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001260556
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 5:37 PM ET
- Size
- 16.5 KB